Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 190

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

A targeted functional RNA interference screen uncovers glypican 5 as an entry factor for hepatitis B and D viruses

Open access
Verrier, Eloi R., Colpitts, Che C., Bach, Charlotte, Heydmann, Laura, Weiss, Amélie, Renaud, Mickaël, Durand, Sarah C., Habersetzer, François, Durantel, David, Abou‐Jaoudé, Georges, López Ledesma, Maria M., Felmlee, Daniel J., Soumillon, Magali, Croonenborghs, Tom, Pochet, Nathalie, Nassal, Michael, Schuster, Catherine, Brino, Laurent, Sureau, Camille, Zeisel, Mirjam B., Baumert, Thomas F.·2016·Hepatology

Abstract

Chronic hepatitis B and D infections are major causes of liver disease and hepatocellular carcinoma worldwide. Efficient therapeutic approaches for cure are absent. Sharing the same envelope proteins, hepatitis B virus and hepatitis delta virus use the sodium/taurocholate cotransporting polypeptide (a bile acid transporter) as a receptor to enter hepatocytes. However, the detailed mechanisms of the viral entry process are still poorly understood. Here, we established a high‐throughput infectious cell culture model enabling functional genomics of hepatitis delta virus entry and infection. Using a targeted RNA interference entry screen, we identified glypican 5 as a common host cell entry factor for hepatitis B and delta viruses. Conclusion: These findings advance our understanding of virus cell entry and open new avenues for curative therapies. As glypicans have been shown to play a role in the control of cell division and growth regulation, virus–glypican 5 interactions may also play a role in the pathogenesis of virus‐induced liver disease and cancer. (H epatology 2016;63:35–48)

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/hep.28013

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 190

Metadata

Authors
Verrier, E. R., Colpitts, C. C., Bach, C., Heydmann, L., Weiss, A., Renaud, M., Durand, S. C., Habersetzer, F., Durantel, D., Abou‐Jaoudé, G., López Ledesma, M. M., Felmlee, D. J., Soumillon, M., Croonenborghs, T., Pochet, N., Nassal, M., Schuster, C., Brino, L., Sureau, C., Zeisel, M. B., & Baumert, T. F.
Venue
Hepatology
Published
2015-10-06
Volume
63
Issue
1
Pages
35-48
ISSN
  • 0270-9139 (ISSN-L)
  • 1527-3350
OpenAlex
W2129105278
Cited by
190
References
4
FWCI
13.76
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A targeted functional RNA interference screen uncovers glypican 5 as an entry factor for hepatitis B and D viruses. https://app.cochat.ai/papers/10.1002/hep.28013
The paper
Verrier, E. R., Colpitts, C. C., Bach, C., Heydmann, L., Weiss, A., Renaud, M., Durand, S. C., Habersetzer, F., Durantel, D., Abou‐Jaoudé, G., López Ledesma, M. M., Felmlee, D. J., Soumillon, M., Croonenborghs, T., Pochet, N., Nassal, M., Schuster, C., Brino, L., Sureau, C., . . . Baumert, T. F. (2016). A targeted functional RNA interference screen uncovers glypican 5 as an entry factor for hepatitis B and D viruses. Hepatology. https://doi.org/10.1002/hep.28013

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.